FDA Approved Medical Products for:

Lennox-Gastaut syndrome

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Rufinamide
Trade Name
(Manufacturer Name)
Banzel®
(Eisai Medical Research, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Adjunctive therapy of seizures associated with Lennox-Gastaut syndrome
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Felbamate
Trade Name
(Manufacturer Name)
Felbatol®
(Meda Pharmaceuticals Inc.)
Indication
The FDA has approved this product to be used in this manner.
As adjunctive therapy in the treatment of partial and generalized seizures associated with the Lennox-Gastaut syndrome in children.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Lamotrigine
Trade Name
(Manufacturer Name)
Lamictal®
(Glaxo Wellcome Research and Development)
Indication
The FDA has approved this product to be used in this manner.
Adjunctive treatment of Lennox-Gastaut syndrome in pediatric and adult patients.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Topiramate
Trade Name
(Manufacturer Name)
Topamax®
(Ortho-McNeil Neurologics)
Indication
The FDA has approved this product to be used in this manner.
As adjunctive therapy in patients two years and older with siezures associated with Lennox-Gastaut syndrome.
More Information about this product Drug Information Portal
Medline Plus Health Information